These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 37823985)

  • 1. Fecal calprotectin in patients with liver cirrhosis.
    Jothimani D; Paramasivam R; Manoharan M; Ramachandran H; Muthusamy S; Simon E; Ravichandran J; Rela M
    Indian J Gastroenterol; 2023 Dec; 42(6):818-823. PubMed ID: 37823985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endoscopic Factors Influencing Fecal Calprotectin Value in Crohn's Disease.
    Goutorbe F; Goutte M; Minet-Quinard R; Boucher AL; Pereira B; Bommelaer G; Buisson A
    J Crohns Colitis; 2015 Dec; 9(12):1113-9. PubMed ID: 26351383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levels of Fecal Calprotectin Are Associated With the Severity of Postoperative Endoscopic Recurrence in Asymptomatic Patients With Crohn's Disease.
    Boschetti G; Laidet M; Moussata D; Stefanescu C; Roblin X; Phelip G; Cotte E; Passot G; Francois Y; Drai J; Del Tedesco E; Bouhnik Y; Flourie B; Nancey S
    Am J Gastroenterol; 2015 Jun; 110(6):865-72. PubMed ID: 25781366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Mucosal Healing in Ulcerative Colitis by Fecal Calprotectin Vs. Fecal Immunochemical Test.
    Takashima S; Kato J; Hiraoka S; Nakarai A; Takei D; Inokuchi T; Sugihara Y; Takahara M; Harada K; Okada H; Tanaka T; Yamamoto K
    Am J Gastroenterol; 2015 Jun; 110(6):873-80. PubMed ID: 25823769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Faecal cytokine profiling as a marker of intestinal inflammation in acutely decompensated cirrhosis.
    Riva A; Gray EH; Azarian S; Zamalloa A; McPhail MJW; Vincent RP; Williams R; Chokshi S; Patel VC; Edwards LA
    JHEP Rep; 2020 Dec; 2(6):100151. PubMed ID: 32838247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fecal Immunochemical Test Versus Fecal Calprotectin for Prediction of Mucosal Healing in Crohn's Disease.
    Inokuchi T; Kato J; Hiraoka S; Takashima S; Nakarai A; Takei D; Sugihara Y; Takahara M; Kawano S; Harada K; Okada H
    Inflamm Bowel Dis; 2016 May; 22(5):1078-85. PubMed ID: 26891256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neopterin is a novel reliable fecal marker as accurate as calprotectin for predicting endoscopic disease activity in patients with inflammatory bowel diseases.
    Nancey S; Boschetti G; Moussata D; Cotte E; Peyras J; Cuerq C; Haybrard J; Charlois AL; Mialon A; Chauvenet M; Stroeymeyt K; Kaiserlian D; Drai J; Flourié B
    Inflamm Bowel Dis; 2013 Apr; 19(5):1043-52. PubMed ID: 23511035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Faecal Calprotectin Is a Very Reliable Tool to Predict and Monitor the Risk of Relapse After Therapeutic De-escalation in Patients With Inflammatory Bowel Diseases.
    Buisson A; Mak WY; Andersen MJ; Lei D; Kahn SA; Pekow J; Cohen RD; Zmeter N; Pereira B; Rubin DT
    J Crohns Colitis; 2019 Aug; 13(8):1012-1024. PubMed ID: 30726887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defining Faecal Calprotectin Thresholds as a Surrogate for Endoscopic and Histological Disease Activity in Ulcerative Colitis-a Prospective Analysis.
    Walsh A; Kormilitzin A; Hinds C; Sexton V; Brain O; Keshav S; Uhlig H; Geddes J; Goodwin G; Peters M; Collins G; Travis S
    J Crohns Colitis; 2019 Mar; 13(4):424-430. PubMed ID: 30445625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fecal calprotectin as a biomarker of microscopic bowel inflammation in patients with spondyloarthritis.
    Campos JF; Resende GG; Barbosa AJA; de Carvalho SC; Lage JA; Cunha PFS; de Souza SCS; Ferrari MLA
    Int J Rheum Dis; 2022 Sep; 25(9):1078-1086. PubMed ID: 35855677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic Accuracy of Fecal Calprotectin for Pediatric Inflammatory Bowel Disease in Primary Care: A Prospective Cohort Study.
    Holtman GA; Lisman-van Leeuwen Y; Kollen BJ; Norbruis OF; Escher JC; Kindermann A; de Rijke YB; van Rheenen PF; Berger MY
    Ann Fam Med; 2016 Sep; 14(5):437-45. PubMed ID: 27621160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum Levels of Metabolites Produced by Intestinal Microbes and Lipid Moieties Independently Associated With Acute-on-Chronic Liver Failure and Death in Patients With Cirrhosis.
    Bajaj JS; Reddy KR; O'Leary JG; Vargas HE; Lai JC; Kamath PS; Tandon P; Wong F; Subramanian RM; Thuluvath P; Fagan A; White MB; Gavis EA; Sehrawat T; de la Rosa Rodriguez R; Thacker LR; Sikaroodi M; Garcia-Tsao G; Gillevet PM
    Gastroenterology; 2020 Nov; 159(5):1715-1730.e12. PubMed ID: 32687928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fecal Calprotectin Is Highly Effective to Detect Endoscopic Ulcerations in Crohn's Disease Regardless of Disease Location.
    Buisson A; Mak WY; Andersen MJ; Lei D; Pekow J; Cohen RD; Kahn SA; Pereira B; Rubin DT
    Inflamm Bowel Dis; 2021 Jun; 27(7):1008-1016. PubMed ID: 33107563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of fecal calprotectin in assessment of hepatic encephalopathy in patients with liver cirrhosis.
    Alempijević T; Štulić M; Popovic D; Culafic D; Dragasevic S; Milosavljevic T
    Acta Gastroenterol Belg; 2014 Sep; 77(3):302-5. PubMed ID: 25509200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving IBD diagnosis and monitoring by understanding preanalytical, analytical and biological fecal calprotectin variability.
    Padoan A; D'Incà R; Scapellato ML; De Bastiani R; Caccaro R; Mescoli C; Moz S; Bozzato D; Zambon CF; Lorenzon G; Rugge M; Plebani M; Basso D
    Clin Chem Lab Med; 2018 Oct; 56(11):1926-1935. PubMed ID: 29729144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accuracies of serum and fecal S100 proteins (calprotectin and calgranulin C) to predict the response to TNF antagonists in patients with Crohn's disease.
    Boschetti G; Garnero P; Moussata D; Cuerq C; Préaudat C; Duclaux-Loras R; Mialon A; Drai J; Flourié B; Nancey S
    Inflamm Bowel Dis; 2015 Feb; 21(2):331-6. PubMed ID: 25625487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic liver failure-consortium acute-on-chronic liver failure and acute decompensation scores predict mortality in Brazilian cirrhotic patients.
    Picon RV; Bertol FS; Tovo CV; de Mattos ÂZ
    World J Gastroenterol; 2017 Jul; 23(28):5237-5245. PubMed ID: 28811718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fecal calprotectin is a useful screening parameter for hepatic encephalopathy and spontaneous bacterial peritonitis in cirrhosis.
    Gundling F; Schmidtler F; Hapfelmeier A; Schulte B; Schmidt T; Pehl C; Schepp W; Seidl H
    Liver Int; 2011 Oct; 31(9):1406-15. PubMed ID: 22093455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fecal calprotectin is equally sensitive in Crohn's disease affecting the small bowel and colon.
    Jensen MD; Kjeldsen J; Nathan T
    Scand J Gastroenterol; 2011 Jun; 46(6):694-700. PubMed ID: 21456899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune dysfunction in cirrhosis: Distinct cytokines phenotypes according to cirrhosis severity.
    Dirchwolf M; Podhorzer A; Marino M; Shulman C; Cartier M; Zunino M; Paz S; Muñoz A; Bocassi A; Gimenez J; Di Pietro L; Romero G; Fainboim H; Fainboim L
    Cytokine; 2016 Jan; 77():14-25. PubMed ID: 26517154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.